Pay in 4 interest-free payments of $6.80 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This innovation significantly enhanced the quality of life for end-stage renal disease (ESRD) patients and reduced reliance on blood transfusions (Schmid and Schiffl, 2010)
When to stop Discontinue and seek medical attention if you experience: severe abdominal pain that does not resolve, persistent vomiting, signs of pancreatitis, changes in vision, or any allergic reaction (difficulty breathing, swelling of face or throat)
Garlicki J, Konturek PC, Majka J, Kwiecien N, Konturek SJ
doi: 10.3389/fnut.2026.1711478 Received 23 September 2025 Revised 03 February 2026 Accepted 11 February 2026 Published 11 March 2026 Volume 13 - 2026 Edited by Patrick Nol Pallier, Queen Mary University of London, United Kingdom Reviewed by Alexander P
US$ 29.54
US$ 22.14
US$ 25.95
US$ 29.31
US$ 25.45
